Federico Grossi - Dec 1, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Federico Grossi
Stock symbol
APLS
Transactions as of
Dec 1, 2022
Transactions value $
-$124,825
Form type
4
Date filed
12/2/2022, 03:30 PM
Previous filing
Nov 3, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$125K -2.5K -2.5% $49.93 97.4K Dec 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.